PRB2 and neoplasm: The most studied PS-binding protein is annexin V. Several radiolabeled annexin V analogs have been developed and evaluated clinically, most notably [99mTc]HYNIC-annexin V. Overall, studies with this tracer showed that annexin V has the capability for binding apoptotic tumor cells and the potential for evaluating tumor response.